{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT06347159",
            "orgStudyIdInfo": {
                "id": "EDG-7500-102"
            },
            "organization": {
                "fullName": "Edgewise Therapeutics, Inc.",
                "class": "INDUSTRY"
            },
            "briefTitle": "A Study of EDG-7500 in Adult Patients With Obstructive Hypertrophic Cardiomyopathy (CIRRUS-HCM)",
            "officialTitle": "An Open-label Study to Evaluate the Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Effects of EDG-7500 in Adults With Obstructive Hypertrophic Cardiomyopathy",
            "therapeuticArea": [
                "Cardiovascular"
            ],
            "study": "a-study-of-edg-in-adult-patients-with-obstructive-hypertrophic-cardiomyopathy-cirrus-hcm"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-06",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2024-04-11",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2025-03",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2025-03",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2024-03-18",
            "studyFirstSubmitQcDate": "2024-04-02",
            "studyFirstPostDateStruct": {
                "date": "2024-04-04",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-06-14",
            "lastUpdatePostDateStruct": {
                "date": "2024-06-17",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Edgewise Therapeutics, Inc.",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "This study is being conducted in order to understand the safety and effects of different doses of EDG-7500 either as a single or multiple dose in adult patients with obstructive hypertrophic cardiomyopathy."
        },
        "conditionsModule": {
            "conditions": [
                "Hypertrophic Cardiomyopathy"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE2"
            ],
            "designInfo": {
                "allocation": "NON_RANDOMIZED",
                "interventionModel": "SEQUENTIAL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 30,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Part A: EDG-7500 Single Dose",
                    "type": "EXPERIMENTAL",
                    "interventionNames": [
                        "Drug: EDG-7500"
                    ]
                },
                {
                    "label": "Part B: EDG-7500 Multiple Dose",
                    "type": "EXPERIMENTAL",
                    "description": "EDG-7500 once daily for up to 28 days.",
                    "interventionNames": [
                        "Drug: EDG-7500"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "EDG-7500",
                    "description": "Liquid suspension formulation of EDG-7500",
                    "armGroupLabels": [
                        "Part A: EDG-7500 Single Dose"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "EDG-7500",
                    "description": "Solid oral formulation of EDG-7500",
                    "armGroupLabels": [
                        "Part B: EDG-7500 Multiple Dose"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Incidence of treatment-emergent adverse events",
                    "timeFrame": "From screening through study completion (Part A: Up to 38 days; Part B: Up to 66 days)"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Change from baseline in left ventricular outflow tract (LVOT) gradient",
                    "description": "Resting and post-Valsalva LVOT gradient by doppler echocardiography",
                    "timeFrame": "From baseline through study completion (Part A: Up to 10 days; Part B: Up to 38 days)"
                },
                {
                    "measure": "Pharmacokinetic parameters of EDG-7500 as measured by maximum plasma concentration (Cmax)",
                    "timeFrame": "Part A: Up to 10 days; Part B: Up to 38 days"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Key Inclusion Criteria:\n\n* Male or nonpregnant female, age \u226518 years.\n* Body mass index (BMI) \u226518 to \\<35 kg/m2; weight \u226550 kg at Screening.\n* Diagnosed with HCM at the time of Screening consistent with current American College of Cardiology Foundation/American Heart Association Guidelines\n* LVOT peak gradient \u226530 mmHg measured at rest and \u226550 mmHg post-Valsalva as determined by echocardiography at Screening.\n* Documented left ventricular ejection fraction (LVEF) \u22650.60 at Screening.\n* New York Heart Association (NYHA) Classification I-III at Screening.\n\nKey Exclusion Criteria:\n\n* Invasive septal reduction \\<180 days prior to Screening.\n* Documented current or history of obstructive coronary artery disease at any time or myocardial infarction \\<180 days prior to Screening.\n* Known Stage B or higher aortic valve stenosis or regurgitation\n* A history of syncope or sustained ventricular tachyarrhythmia \\<180 days prior to Screening.\n* A history of sudden cardiac arrest at any time or known appropriate implantable cardioverter defibrillator (ICD) discharge \\<180 days prior to Screening\n* Atrial fibrillation (AF) at Screening; a current diagnosis of permanent AF; paroxysmal or persistent AF \\<90 days of Screening, or electrical cardioversion or ablation for AF \\<90 days of Screening.\n* Fridericia-corrected QT interval (QTcF) \u2265480 ms or any other ECG abnormality considered by the Investigator to pose a risk to participant safety.\n* Current or prior use of any cardiac myosin inhibitors",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Edgewise Therapeutics",
                    "role": "CONTACT",
                    "phone": "720-262-7002",
                    "email": "cardiacstudies@edgewisetx.com"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Medical Director",
                    "affiliation": "Edgewise Therapeutics, Inc.",
                    "role": "STUDY_DIRECTOR"
                }
            ],
            "locations": [
                {
                    "facility": "University of California, San Francisco",
                    "status": "RECRUITING",
                    "city": "San Francisco",
                    "state": "California",
                    "zip": "94143",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Edgewise Therapeutics, Inc",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 37.77493,
                        "lon": -122.41942
                    }
                },
                {
                    "facility": "The Lindner Research Center at Christ Hospital",
                    "status": "RECRUITING",
                    "city": "Cincinnati",
                    "state": "Ohio",
                    "zip": "45219",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Edgewise Therapeutics, Inc.",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.12713,
                        "lon": -84.51435
                    }
                },
                {
                    "facility": "Hospital of the University of Pennsylvania (University of Pennsylvania School of Medicine)",
                    "status": "RECRUITING",
                    "city": "Philadelphia",
                    "state": "Pennsylvania",
                    "zip": "19104",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Edgewise Therapeutics, Inc.",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.95233,
                        "lon": -75.16379
                    }
                }
            ]
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000009202",
                    "term": "Cardiomyopathies"
                },
                {
                    "id": "D000002312",
                    "term": "Cardiomyopathy, Hypertrophic"
                },
                {
                    "id": "D000006984",
                    "term": "Hypertrophy"
                }
            ],
            "ancestors": [
                {
                    "id": "D000006331",
                    "term": "Heart Diseases"
                },
                {
                    "id": "D000002318",
                    "term": "Cardiovascular Diseases"
                },
                {
                    "id": "D000020763",
                    "term": "Pathological Conditions, Anatomical"
                },
                {
                    "id": "D000001020",
                    "term": "Aortic Stenosis, Subvalvular"
                },
                {
                    "id": "D000001024",
                    "term": "Aortic Valve Stenosis"
                },
                {
                    "id": "D000082862",
                    "term": "Aortic Valve Disease"
                },
                {
                    "id": "D000006349",
                    "term": "Heart Valve Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M12154",
                    "name": "Cardiomyopathies",
                    "asFound": "Cardiomyopathy",
                    "relevance": "HIGH"
                },
                {
                    "id": "M10035",
                    "name": "Hypertrophy",
                    "asFound": "Hypertrophic",
                    "relevance": "HIGH"
                },
                {
                    "id": "M5568",
                    "name": "Cardiomyopathy, Hypertrophic",
                    "asFound": "Hypertrophic Cardiomyopathy",
                    "relevance": "HIGH"
                },
                {
                    "id": "M9419",
                    "name": "Heart Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M22519",
                    "name": "Pathological Conditions, Anatomical",
                    "relevance": "LOW"
                },
                {
                    "id": "M4340",
                    "name": "Aortic Valve Stenosis",
                    "relevance": "LOW"
                },
                {
                    "id": "M6475",
                    "name": "Constriction, Pathologic",
                    "relevance": "LOW"
                },
                {
                    "id": "M2379",
                    "name": "Aortic Valve Disease",
                    "relevance": "LOW"
                },
                {
                    "id": "M9437",
                    "name": "Heart Valve Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "T449",
                    "name": "Aortic Valve Stenosis",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC14",
                    "name": "Heart and Blood Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        }
    },
    "hasResults": false
}